CRO/CMO

September 12, 2018

The Future of BioManufacturing: Automated Closed Systems for Cell & Gene Therapy Processes

July 12, 2018
Global Drug Development IPOs: NASDAQ Dominance Continues as 26 Companies Raise Over $2.54B in Q2

Global Drug Development IPOs: NASDAQ Dominance Continues as 26 Companies Raise Over $2.54B in Q2

[vc_row][vc_column][vc_column_text]The Drug Development IPO market enjoyed a strong second quarter, with over $2.54B raised by 26 companies across the globe. 85% of companies that listed during […]
June 4, 2018

The Future of BioManufacturing: In Silico Modelling

April 12, 2018
Lonza Opens World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas

Lonza Opens World’s Largest Cell & Gene Therapy Manufacturing Plant in Texas

[vc_row][vc_column][vc_column_text] Swiss CDMO Lonza recently opened the world’s biggest manufacturing plant to produce custom viruses for use in cell and gene therapies. The facility, based in […]
March 8, 2018
Charles River Laboratories M&A Activity Analysis: a Differentiated Strategy Delivering Results

Charles River Laboratories M&A Activity Analysis: A Differentiated Strategy Delivering Results

[vc_row][vc_column][vc_column_text] From its early days as one the first suppliers of animal models for research in 1947, Charles River Laboratories (CRL) has developed into a brand […]
February 22, 2018
Making Large-Scale Biomanufacturing More Efficient and Affordable: Have Novo Nordisk Foundation Made a Major Breakthrough?

Making Large-Scale Biomanufacturing More Efficient and Affordable: Have Novo Nordisk Foundation Made a Major Breakthrough?

[vc_row][vc_column][vc_column_text] The Novo Nordisk Foundation Centre for Biosustainability recently published an exciting finding that could herald the beginning of utilising bioproduction for the large-scale manufacture of […]
January 30, 2018
GLOBAL DRUG DEVELOPMENT IPOs: $6.4B Raised as Bullish Investors Back Biologics & Gene Therapies Despite Slowed Growth in 2017

Global Therapeutic IPO Review: $6.4B Raised as Bullish Investors Back Biologics & Gene Therapies Despite Slowed Growth in 2017

[vc_row][vc_column][vc_column_text]2017 saw a total of 73 Drug Development IPOs across 15 global exchanges, compared to 58 IPOs in 2016. In total approximately $6.4B was raised, 1% […]
December 8, 2017

The Future of BioManufacturing: Downstream Processing

October 5, 2017
Slow Quarter for the Global Therapeutic IPO Market: 13 Companies Raise Over $1B in Q3 2017

2017 Global Therapeutic IPO Market: 121% YOY Increase in Funds Raised Despite Slow Q3

[vc_row][vc_column][vc_column_text] The global therapeutic IPO market has failed to maintain the upward momentum established throughout a busy Q2 2017, with just over $1B raised by 13 […]
Contact Us